IT1293795B1 - Farmaco attivo nel ridurre la produzione di proteina mcp-1 - Google Patents

Farmaco attivo nel ridurre la produzione di proteina mcp-1

Info

Publication number
IT1293795B1
IT1293795B1 IT97MI001789A ITMI971789A IT1293795B1 IT 1293795 B1 IT1293795 B1 IT 1293795B1 IT 97MI001789 A IT97MI001789 A IT 97MI001789A IT MI971789 A ITMI971789 A IT MI971789A IT 1293795 B1 IT1293795 B1 IT 1293795B1
Authority
IT
Italy
Prior art keywords
mcp
protein
reducing
production
drug active
Prior art date
Application number
IT97MI001789A
Other languages
English (en)
Italian (it)
Inventor
Angelo Guglielmotti
Alberto Mantovani
Original Assignee
Angelini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT97MI001789A priority Critical patent/IT1293795B1/it
Application filed by Angelini Ricerche Spa filed Critical Angelini Ricerche Spa
Priority to PT98943862T priority patent/PT1005332E/pt
Priority to DK98943862T priority patent/DK1005332T3/da
Priority to SI9830573T priority patent/SI1005332T1/xx
Priority to CA002300289A priority patent/CA2300289C/en
Priority to AU91601/98A priority patent/AU744492B2/en
Priority to EP98943862A priority patent/EP1005332B1/en
Priority to JP2000503829A priority patent/JP4651191B2/ja
Priority to DE69819012T priority patent/DE69819012T2/de
Priority to AT98943862T priority patent/ATE251902T1/de
Priority to HK00107851.3A priority patent/HK1028561B/en
Priority to PCT/EP1998/004924 priority patent/WO1999004770A2/en
Priority to ES98943862T priority patent/ES2207858T3/es
Priority to US09/463,666 priority patent/US6534534B1/en
Priority to ZA986636A priority patent/ZA986636B/xx
Priority to ARP980103695A priority patent/AR016382A1/es
Publication of ITMI971789A1 publication Critical patent/ITMI971789A1/it
Application granted granted Critical
Publication of IT1293795B1 publication Critical patent/IT1293795B1/it
Priority to JP2009270715A priority patent/JP5086322B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT97MI001789A 1997-07-28 1997-07-28 Farmaco attivo nel ridurre la produzione di proteina mcp-1 IT1293795B1 (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT97MI001789A IT1293795B1 (it) 1997-07-28 1997-07-28 Farmaco attivo nel ridurre la produzione di proteina mcp-1
HK00107851.3A HK1028561B (en) 1997-07-28 1998-07-22 Pharmaceutical composition for reducing production of mcp-1 protein
SI9830573T SI1005332T1 (en) 1997-07-28 1998-07-22 Pharmaceutical composition for reducing production of mcp-1 protein
CA002300289A CA2300289C (en) 1997-07-28 1998-07-22 A pharmaceutical composition active in reducing production of mcp-1 protein
AU91601/98A AU744492B2 (en) 1997-07-28 1998-07-22 A pharmaceutical composition active in reducing production of mcp-1 protein
EP98943862A EP1005332B1 (en) 1997-07-28 1998-07-22 Pharmaceutical composition for reducing production of mcp-1 protein
JP2000503829A JP4651191B2 (ja) 1997-07-28 1998-07-22 Ｍｃｐ−１タンパク質の生成を減らす際に活性がある薬剤組成物
DE69819012T DE69819012T2 (de) 1997-07-28 1998-07-22 Pharmazeutische zusammensetzung zur reduzierung der mcp-1 proteinsynthese
PT98943862T PT1005332E (pt) 1997-07-28 1998-07-22 Composicao farmaceutica para reduzir a producao da proteina mcp-1
DK98943862T DK1005332T3 (da) 1997-07-28 1998-07-22 Farmaceutisk præparat til reduktion af produktion af MCP-1-protein
PCT/EP1998/004924 WO1999004770A2 (en) 1997-07-28 1998-07-22 A pharmaceutical composition active in reducing production of mcp-1 protein
ES98943862T ES2207858T3 (es) 1997-07-28 1998-07-22 Composicion farmaceutica activa para reducir la produccion de proteina mcp-1".
US09/463,666 US6534534B1 (en) 1997-07-28 1998-07-22 Pharmaceutical composition active in reducing production of MCP-1 protein
AT98943862T ATE251902T1 (de) 1997-07-28 1998-07-22 Pharmazeutische zusammensetzung zur reduzierung der mcp-1 proteinsynthese
ZA986636A ZA986636B (en) 1997-07-28 1998-07-24 A pharmaceutical composition active in reducing production of MCP-1 protein
ARP980103695A AR016382A1 (es) 1997-07-28 1998-07-28 Uso de un derivado del acido bencil-indazol metoxialcanoico.
JP2009270715A JP5086322B2 (ja) 1997-07-28 2009-11-09 Ｍｃｐ−１プロテインの増加生産によって特徴付けられる障害の処置のための薬剤組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001789A IT1293795B1 (it) 1997-07-28 1997-07-28 Farmaco attivo nel ridurre la produzione di proteina mcp-1

Publications (2)

Publication Number Publication Date
ITMI971789A1 ITMI971789A1 (it) 1999-01-28
IT1293795B1 true IT1293795B1 (it) 1999-03-10

Family

ID=11377642

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI001789A IT1293795B1 (it) 1997-07-28 1997-07-28 Farmaco attivo nel ridurre la produzione di proteina mcp-1

Country Status (15)

Country Link
US (1) US6534534B1 (enExample)
EP (1) EP1005332B1 (enExample)
JP (2) JP4651191B2 (enExample)
AR (1) AR016382A1 (enExample)
AT (1) ATE251902T1 (enExample)
AU (1) AU744492B2 (enExample)
CA (1) CA2300289C (enExample)
DE (1) DE69819012T2 (enExample)
DK (1) DK1005332T3 (enExample)
ES (1) ES2207858T3 (enExample)
IT (1) IT1293795B1 (enExample)
PT (1) PT1005332E (enExample)
SI (1) SI1005332T1 (enExample)
WO (1) WO1999004770A2 (enExample)
ZA (1) ZA986636B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
LT2254869T (lt) 2008-03-07 2017-08-10 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Nauji 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydyme ligų, susijusių su cx3cr1 ir p40 raiška
CA2714436C (en) 2008-03-07 2017-06-27 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
JP5509102B2 (ja) 2008-03-07 2014-06-04 アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニ 新規な１−ベンジル−３−ヒドロキシメチルインダゾール誘導体およびそのｍｃｐ−１およびｃｘ３ｃｒ１の発現に基づく疾患の治療への使用
PL2462119T3 (pl) 2009-08-03 2014-10-31 Acraf Sposób wytwarzania 1-benzylo-3-hydroksymetylo-1H-indazolu i jego pochodnych oraz potrzebnych magnezowych związków pośrednich
UA108742C2 (uk) * 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US9250253B2 (en) 2010-02-25 2016-02-02 Prairie Ventures, L.L.C. System and method for anatomical pathology sample handling, storage, and analysis
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
EP3142664B1 (en) * 2014-05-15 2019-12-04 Translatum Medicus Inc. Compositions and methods for treating and diagnosing ocular disorders
WO2016201426A1 (en) 2015-06-12 2016-12-15 Vettore, LLC Mct4 inhibitors for treating disease
IL279949B2 (en) 2016-12-12 2025-03-01 Vettore Llc Heterocyclic MCT4 inhibitors
US11753382B2 (en) 2019-06-25 2023-09-12 Translatum Medicus Inc. Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230441B (it) 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
WO1994009128A1 (en) * 1992-10-22 1994-04-28 Mallinckrodt Medical, Inc. Therapeutic treatment for inhibiting vascular restenosis
US5563145A (en) * 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines
JPH08333262A (ja) * 1995-04-07 1996-12-17 Chugai Pharmaceut Co Ltd 免疫抑制剤
US6113898A (en) * 1995-06-07 2000-09-05 Idec Pharmaceuticals Corporation Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
DE19538402A1 (de) * 1995-10-14 1997-04-17 Boehringer Mannheim Gmbh Lipidalkohole als neue immunsuppressive und antivirale Arzneimittel
JPH09165339A (ja) * 1995-10-27 1997-06-24 American Home Prod Corp ラパマイシンを付与したドナー脾細胞を用いる臓器移植の延長
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
US5780462A (en) * 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1

Also Published As

Publication number Publication date
CA2300289A1 (en) 1999-02-04
JP2010047609A (ja) 2010-03-04
HK1028561A1 (en) 2001-02-23
SI1005332T1 (en) 2004-02-29
US6534534B1 (en) 2003-03-18
DE69819012D1 (de) 2003-11-20
JP5086322B2 (ja) 2012-11-28
DK1005332T3 (da) 2004-02-09
AR016382A1 (es) 2001-07-04
WO1999004770A3 (en) 1999-04-15
ZA986636B (en) 1999-02-04
AU744492B2 (en) 2002-02-28
JP4651191B2 (ja) 2011-03-16
AU9160198A (en) 1999-02-16
JP2001510793A (ja) 2001-08-07
CA2300289C (en) 2007-11-20
ES2207858T3 (es) 2004-06-01
WO1999004770A2 (en) 1999-02-04
ITMI971789A1 (it) 1999-01-28
PT1005332E (pt) 2004-03-31
EP1005332A2 (en) 2000-06-07
DE69819012T2 (de) 2004-08-12
ATE251902T1 (de) 2003-11-15
EP1005332B1 (en) 2003-10-15

Similar Documents

Publication Publication Date Title
NL300952I2 (nl) Peramivir en farmaceutisch aanvaardbare zouten daarvan
ITMI950568A0 (it) Formulazioni farmaceutiche in forma di gel tissotropico
PT1028954E (pt) Imidazoles substituidos uteis no tratamento de doencas inflamatorias
FI952033A7 (fi) Farmakologisesti aktiiviset pyrrolopyrimidiinijohdannaiset
ID23874A (id) Obat
DE69513671D1 (de) Arzneimittel
DE69829139D1 (de) Medikator vom ansangtyp
DE69908021D1 (de) Ziprasidonhaltige Arzneimittel
ID18663A (id) Komposisi farmasi berlapis enterik
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
PT1083171E (pt) Derivados de pirazolina sua preparacao e aplicacao como medicamentos
ID24654A (id) Formulasi farmasi omeprazola
PT1095025E (pt) Benzimidazoles sua producao e sua utilizacao como medicamentos
IT1293795B1 (it) Farmaco attivo nel ridurre la produzione di proteina mcp-1
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
PT1006110E (pt) Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
IT1291366B1 (it) Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
DK1017392T3 (da) Lægemiddel
PT1043307E (pt) Derivados de 3-amino-3-arilpropan-1-ol sua producao e utilizacao
PT768304E (pt) N-(pirimidinil)-benzenossulfonamidas como medicamentos
DE69837507D1 (de) Humanes Hedgehog-Protein
NO991458D0 (no) Antimykotisk gel med h°y virkestoff-frigivelse
IT1293794B1 (it) Farmaco attivo nel ridurre la produzione di proteina mcp-1
DE59602953D1 (de) Fungizide wirkstoffkombinationen
DE59602890D1 (de) Fungizide wirkstoffkombinationen

Legal Events

Date Code Title Description
0001 Granted